A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen
Latest Information Update: 04 Mar 2021
At a glance
- Drugs Celecoxib (Primary) ; Ibuprofen; Naproxen
- Indications Osteoarthritis; Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms PRECISION
- Sponsors Pfizer
- 20 May 2020 Results assessing cost effectiveness and quality of life of celecoxib versus ibuprofen and naproxen in patients with osteoarthritis, presented at the 25th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 18 Mar 2019 Results (n=23,953) evaluating clinical predictors of cardiovascular outcomes were presented at the 68th Annual Scientific Session of the American College of Cardiology.
- 28 Jun 2018 According to a FDA media release, based on this study results, the U.S. Food and Drug Administration has approved a labeling supplement for Celebrex (celecoxib).